Related Experiment Video
Updated: Feb 2, 2026

Monitoring Kinase and Phosphatase Activities Through the Cell Cycle by Ratiometric FRET
Published on: January 27, 2012
Identification of Kinases and Phosphatases That Regulate ATG4B Activity by siRNA and Small Molecule Screening in
Niccolo Pengo1, Krisna Prak1, Joana R Costa1
1MRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.
Abstract:
Autophagy protease ATG4B is a key regulator of the LC3/GABARAP conjugation system required for autophagosome formation, maturation and closure. Members of the ATG4 and the LC3/GABARAP family have been implicated in various diseases including cancer, and targeting the ATG4B protease has been suggested as a potential therapeutic anti-cancer strategy. Recently, it has been demonstrated that ATG4B is regulated by multiple post-translational modifications, including phosphorylation and de-phosphorylation. In order to identify regulators of ATG4B activity, we optimized a cell-based luciferase assay based on ATG4B-dependent release of Gaussia luciferase. We applied this assay in a proof-of-concept small molecule compound screen and identified activating compounds that increase cellular ATG4B activity. Next, we performed a high-throughput screen to identify kinases and phosphatases that regulate cellular ATG4B activity using siRNA mediated knockdown and cDNA overexpression. Of these, we provide preliminary evidence that the kinase AKT2 enhances ATG4B activity in cells. We provide all raw and processed data from the screens as a resource for further analysis. Overall, our findings provide novel insights into the regulation of ATG4B and highlight the importance of post-translational modifications of ATG4B.
Insights
Researchers identified regulators of autophagy protease ATG4B, crucial in cancer. A new assay revealed compounds activating ATG4B and identified AKT2 kinase as a key enhancer of its cellular activity.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Autophagy protease ATG4B regulates the LC3/GABARAP system, essential for autophagosome formation.
- Dysregulation of ATG4B and related proteins is linked to diseases, notably cancer, making ATG4B a therapeutic target.
- Post-translational modifications, such as phosphorylation and dephosphorylation, are known regulators of ATG4B activity.
Purpose of the Study:
- To identify novel regulators of cellular ATG4B activity.
- To develop and validate a cell-based assay for screening ATG4B modulators.
- To discover small molecules and protein kinases/phosphatases that impact ATG4B function.
Main Methods:
- Optimization of a cell-based luciferase assay measuring ATG4B-dependent Gaussia luciferase release.
- Proof-of-concept small molecule compound screen to identify ATG4B activators.
- High-throughput screening using siRNA knockdown and cDNA overexpression to identify regulatory kinases and phosphatases.
Main Results:
- Successful optimization of a cell-based assay for ATG4B activity.
- Identification of small molecule compounds that enhance cellular ATG4B activity.
- Preliminary evidence suggests the kinase AKT2 positively regulates ATG4B activity in cells.
Conclusions:
- Novel insights into the post-translational regulation of ATG4B activity have been uncovered.
- The developed assay serves as a valuable tool for future drug discovery targeting ATG4B.
- Understanding ATG4B regulation is critical for developing targeted cancer therapies.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Positive Regulator Molecules
Positive Regulator Molecules
Negative Regulator Molecules
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

